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Editorial
Highlights from the 6th International Meeting on Emerging Diseases and
Surveillance (IMED 2016) Vienna, Austria from Nov 3 to 7, [1_TD$DIFF] 2016
[4_TD$DIFF]Zika Virus, MERS-CoV, Avian Inﬂuenza, Yellow Fever and
Antimicrobial Resistance – Emerging and Re-Emerging Health
Threats
Emerging infectious diseases remain at the center of theworld’s
attention. The current threats posed by Zika, Yellow Fever, MERS-
CoV, and pandemic inﬂuenza, the recent Ebola outbreak that
devastated West Africa, and the realization that new infectious
diseases may be recognized at any time, in any place, has
dramatically increased public awareness of infectious diseases and
underscored the need to understand emerging pathogens. As with
each prior iteration, IMED 2016 fully embodied the ‘‘One Health’’
model of emerging diseases, recognizing the commonality of
human, environmental and animal health by bringing together
human and veterinary health clinicians, scientists, and policy
makers frommore than 100 countries.Withmore than 90 talks and
400 poster presentations, it’s impossible to adequately summarize
all of the important insights conveyed at IMED 2016. Here is a
sampling of some of the topics that caught our interest.
[5_TD$DIFF] MED 2016 Hackathon
The 2016 meeting incorporated a new participatory program, a
hackathon or invention marathon, at the intersection of emerging
diseases and technology (http://www.hackathon.isid.org). Proto-
type projects that emerged from the Hackathon spanned from
predicting malaria cases in Uganda in real time using climate data
to developing a tool to allow humanitarian organizations to easily
assess the environmental impact of their operations; improved
communication tools to prevent outbreaks; a participatory mobile
app to help eradicate rabies in Indonesia; integrated disease
surveillance platforms and an improved search function for the
ProMED archives based on text recognition.
[6_TD$DIFF] he Century of Epidemics
IMED 2016 speakers from all regions of the world agreed that
over the course of the coming century, epidemics are likely to occur
more frequently, as will the risk of global pandemics. The world’s
increasing population, higher demand for protein, climate change,
increasing mobility, social vulnerability and political instability
were only a few of the factors discussed that contribute to the
projected increase. At the same time, rapid advances in science and
improvements in technology and data sharing offer new ways to
prevent, detect, predict and respond to those threats. Although we
are not able to prepare when, where or which pathogen will
emerge next, we will be better prepared to prevent the next
pandemic. The general public’s interest in emerging infectious
diseases was highlighted in a poster presentation by Dr. [17_TD$DIFF] aniel
Lucey and colleagues, who showed details of a planned exhibit on
‘‘Exploring Pandemics: A Smithsonian museum endeavor for the
public’’ at the Smithsonian National Museum of Natural History in
Washington, DC. The exhibit is scheduled to open in early
2018 through early 2020, coinciding with the 100-year commem-
oration of the 1918-1920 Inﬂuenza pandemic and will offer the
public an opportunity to explore and understand better 10 epi-
demics caused by zoonotic viruses from around the world.
[7_TD$DIFF]One World – One Health: Transboundary Emerging Diseases in
Humans, Animals and Wildlife
IMED opened with a plenary session dedicated to transbound-
ary emerging diseases in an increasingly interconnected world.
Professor Albert Osterhaus talked about HIV, Avian ﬂu, SARS,
MERS-CoV, Ebola and Zika as some of the diseases that originated
in animals and passed to humans. While many of these have been
well studied, there remain signiﬁcant gaps in understanding the
linkages of infection, making it challenging to predict and prepare
for the next epidemic. Several speakers presented results on
studies that further examined zoonotic disease spread and aimed
at identifying pathogens and environments most conducive to
spillover to humans. Professor Christine Kreuder Johnson and
Professor Rudovick Kazwala discussed results from USAID’s
Emerging Pandemic Threats PREDICT project, that uses a risk-
based strategy to investigate emerging diseases threats. Dr.
Kreuder Johnson’s team examined common animal hosts and
convergent mechanisms involved in past spillovers of zoonotic
viruses in order to identify high-risk interfaces for surveillance
activities and interventions aimed at prevention. The team found
that viruses transmitted to humans had signiﬁcantly higher host
plasticity. In other words, they were reported in a more
taxonomically diverse host range. Viruses with higher host
plasticity were also more likely to amplify viral spillover by
secondary human-to-human transmission and have broader
geographic spread. Dr. Kazwala reported on results from the
PREDICT project in Tanzania where bats, rodents and non-human
primateswere subjected tomolecular virology diagnostic tests and
revealed the presence of 64 viruses including 48 novel viruses.
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During the oral abstract presentation session on One Health –
Diseases Across Species Boundaries, Toph Allen from EcoHealth
Alliance and colleagues shared results from an updated model
assessing the global distribution of zoonotic emerging infectious
disease risk. Highest risk of emergence was concentrated in
tropical regions where wildlife biodiversity is high, human
populations dense and growing, and land use change is occurring
rapidly. These regions were thought most likely to produce the
next emerging infectious disease event, and therefore most
valuable for surveillance in wildlife, livestock or people. Dr.
[18_TD$DIFF] reen Shanta and colleagues from the International Centre for
Diarrheal Disease Research in Bangladesh reported data from a
cross sectional survey of 9,512 households to identify hotspots of
human exposure to rodents, bats andmonkeys in Bangladesh. They
concluded that more than 13.6 million people in Bangladesh are
exposed to rodents each month, more than 800,000 to bats and
more than 80,000 to monkeys putting them at risk for contacts to
pathogens from those species.
To identify early signals for the emergence, spill over and spread
of animal pathogens, Dr. Julio Pinto (Food and Agricultural
Organization of the UN) then called for a new mindset in the
way the international community coordinates and manages
disease emergence. The new approach should be multi-disciplin-
ary and should strengthen local capacities in epidemiological
analysis, use open analytical tools and GIS platforms, integrate new
technologies such as mobile devices and rapid diagnostics and be
committed to the open sharing of data.
[8_TD$DIFF] laviviruses - An Expanding Global Threat
Since the last IMED, ﬂaviviruses have emerged as prominent
threats in the world. The ﬂavivirus session addressed the ongoing
Zika virus epidemic in the Americas and other regions of the world
and the Yellow fever virus outbreak in Africa, which threatened to
go global. A major concern of the Zika virus epidemic is the
association ofmaternal infectionwith birth defects, a complication
that has not been seen with ﬂavivirus infections in humans in the
past but has been seen with congenital infections in animals.
Professor James MacLachlan discussed what is known about
congenital infections of animals with ﬂaviviruses and highlighted
the critical role of the timing of infection. For example, infections
with Bluetongue virus (BTV) have clearly shown the critical role of
gestational age in determining outcome. Fetuses infected prior to
mid-gestation that survive congenital BTV infection are born with
cavitating central nervous system defects that range from severe
hydranencephaly to cerebral cysts (porencephaly). Bunyaviruses
cause gestational age-dependent teratogenesis in fetal ruminants
but, in addition to cavitating central nervous system defects,
affected fetuses are born with contracted limbs - congenital
hydranencephaly/arthrogryposis syndrome. Dr. Vanessa van der
Linden, a pediatric neurologist from Recife, in Northeastern Brazil
then gave a heartbreaking description of Zika [19_TD$DIFF]-related neurologic
complications. Recife is one of the areas hardest hit by the Zika
epidemic and Dr. van der Linden was one of the ﬁrst to recognize
the microcephaly epidemic in this area. She reported patients
suffering from the full range of manifestations including craniofa-
cial disproportion, spasticity, seizures, irritability, brainstem
dysfunction, limb contractures including arthrogryposis, hearing
and ocular abnormalities, and brain anomalies detected by
neuroimaging. She emphasized the importance of vigilant health
professionals to recognize changes in the neurodevelopment
during the ﬁrst years of life and the necessity of a team approach
to provide the best care to affected children and support for their
families.
Professor Oyewale Tomori from Nigeria highlighted the
Angolan Yellow Fever outbreak, the largest in 30 years, that
spread to neighboring countries, and quite worrisomely via
travelers to Asia. Despite the long availability of an effective
vaccine, the shift of hotspots fromWest to Central Africa, failures of
vaccination policy and vaccine shortages combined to produce this
global threat.
[9_TD$DIFF]Epidemics Without Borders
Rapid urbanization, mass population movements, climate
change, and resistance to pesticides and available treatments
increase the risk of epidemics in the future, argued Dr. Mercedes
Tatay from Doctors Without Borders. Current strategies to prevent
major outbreaks of disease show limited success. Epidemics
continue to occur with devastating consequences for less
developed countries. She argued that in reality, not all epidemics
are viewed equally. The global health security concept at the heart
of the International Health Regulations deﬁnes protection against a
threat as the main trigger for international action. She concluded
that emergency response needs to be prioritized not in competi-
tion with long-term goals such as public health surveillance and
health systems strengthening.
[10_TD$DIFF]Global Pandemic Preparedness
West Africa’s Ebola epidemic was unprecedented with more
than 28,000 reported cases, more than 11,000 reported deaths and
more than 10,000 survivors. In response to the epidemic, four
global commissions were established to critically evaluate the
national and global response and to enhance preparedness to
prevent, detect, and respond to future infectious disease threats.1 [15_TD$DIFF]
Professor [17_TD$DIFF] aniel Lucey summarized the commissions’ recommen-
dations including the importance of strengthening national health
systems, consolidating and strengthening World Health Organiza-
tion (WHO) emergency and outbreak response activities, and
enhancing research and development. WHO agreed to one of the
most profound transformations in the Organization’s history by
establishing a new Health Emergencies Programme. The pro-
gramme is designed to add operational capabilities for outbreaks
and humanitarian emergencies to complement its traditional
technical and normative roles. Similarly, the recommendations of
the Review Committee on the role of the International Health
Regulations (IHR) was focused on the implementation aspects of
the IHR.
The implementation of a vaccine trial during an epidemic was
discussed by Dr. Barbara Mahon, US CDC Lead for the Sierra Leone
Trial to Introduce a Vaccine against Ebola (STRIVE), a phase 2/3 trial
sponsored by CDC in collaboration with the College of Medicine
and Allied Health Sciences, University of Sierra Leone, and the
Ministry of Health and Sanitation.2 The trial was designed to
accelerate introduction and use of the recombinant vesicular
stomatitis virus Zaire Ebola vaccine (rVSV-ZEBOV) among at-risk
people in Sierra Leone with concurrent evaluation of the efﬁcacy
and safety of the vaccine. She talked about the challenges
implementing STRIVE in the face of limited infrastructure, high
community concern, and changing epidemiology. Preliminary
analysis of safety data indicated no vaccine-related deaths or other
serious adverse events; Although STRIVE did not produce an
estimate of vaccine efﬁcacy because of low case frequency as the
epidemic was controlled, data on safety and immunogenicity will
support decisions on licensure of rVSV-ZEBOV.
The importance of open data sharing during epidemics and
ethical challenges of using big data for early detection and
prevention were discussed during a roundtable discussion
moderated by Professor Effy Vayenna who was joined by experts
from the WHO, the Wellcome Trust and the Centre on Global
Health Security (Chatham House, London). The importance of
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communicating to the press and public during an outbreak and
how to best communicate uncertainty was reviewed by Helen
Branswell of the US-based STAT news. She noted the importance of
building rapport between public health authorities, scientists and
journalists prior to the onset of an outbreak. Dr. Edward Rubin
presented advances in diagnosis and how the genomic revolution
and acceleration of DNA sequencing throughput allows us to
increasingly consider unbiased metagenomic analysis as a tool to
detect emerging diseases. The lack of therapeutics for the next viral
epidemic were discussed by Professor Paul Tambyah.
In a separate session, the challenges posed by climate change on
infectious disease outbreaks and how to best prevent and track
diseases in mobile populations were discussed. Dr. Joel Mon-
tgomery stated that while researchers are understanding how
changes in temperature, precipitation and vegetation phenology
impact malaria and certain arbovirus vectors, relatively less
attention has been paid to the impact of climate change on
neglected tropical diseases (NTD) and the challenges migration
may pose to NTD elimination efforts.
[11_TD$DIFF] racking Emerging Diseases
The ‘‘Tracking Emerging Diseases’’ session highlighted innova-
tions in disease surveillance and the increasing role of informal
sources to detect unusual health events early. Dr. Mark Smolinski,
the Chief Medical Ofﬁcer and Director of Global Health Threats at
the Skoll Global Threats Fund described a transformation of
citizen engagement in public health through systems that
empower users to directly report on symptoms of disease via
email and smartphone technology. These new and innovative
systems provide earlywarning for outbreaks and other health and
safety issues, even before users seek health care, and have the
potential to transform rapid risk assessment and epidemiological
studies. Further exploring the role of informal data sources to
detect outbreaks earlier, Professor Anna Thorner discussed how
physician searches using UpToDate – an evidence based, online,
clinical decisionmaking tool that is continuously updated - can be
used to detect outbreaks early on before cases are reported and
conﬁrmed.
[12_TD$DIFF]A Refugee’s Journey from Insecurity to Stability
The European migrant crisis has raised questions regarding the
re-emergence of infectious diseases and the monitoring and
screening of migrants arriving in Europe and elsewhere. In a
session presented in collaboration with the European Society for
Clinical Microbiology and Infectious Diseases, physicians from
Germany and Turkey, both countries with a recent high inﬂux of
refugees, talked about their countries’ challenges and experiences
in providing health care and preventive services to refugees and
asylum seekers. They called for uniform screening practices and
early access to primary and specialized healthcare and emphasized
the need for appropriate vaccination coverage. Theywere joined by
colleagues from Italy and Switzerland discussing the related topics
of disease surveillance and tracing antibiotic resistance in mobile
populations.
[13_TD$DIFF]Antimicrobial Resistance in the One Health Context
Antibiotic resistance is amajor global public health concern and
resistance is growing faster than new drugs are being developed.
Antibiotic resistance needs to be understood in the One Health
context. The importance of the food chain as a source for emergence
and spread of antimicrobial resistance between animals and
humans was highlighted in a nation-wide study in Lebanon. Dr.
GhassanMatar described a direct transfer of resistant determinants
in bacterial clones from animal food products to humans. But
understanding antimicrobial resistance is expanding even further,
from human and animal antibiotic use to the human inﬂuence on
resistance in the environment. Dr. Ursula Theuretzbacher noted
that the link between the animal and human sector was well
studied and led to policy changes in some parts of the world. Such
regulatory initiatives are still missing in the environmental ﬁeld
which is usually not included in the One Health approach to tackle
the global resistance problem. The direct release of multidrug
resistant bacteria from healthcare settings, antibiotic manufactur-
ing facilities and animal farms into the environment as well as the
pollution of the environment with high concentrations of anti-
biotics create a dangerous resistance reservoir.
[14_TD$DIFF]Know your enemy
Drs. Peter Daszak and Dennis Carroll closed IMED 2016 with a
plenary talk on the proposed ‘‘Global Virome Project’’, a global
initiative to map all of the planet’s viral threats over the next
10 years which would represent a dramatic step towards knowing
our viral enemy. Researchers so far have identiﬁed only the tip of
the iceberg of viral threats and even fewer of these viruses had
effective vaccines or antiviral agents developed. The speakers
presented viral discovery data estimating that there are around
500,000 yet-to-be-discovered viral species capable of posing
public health threats circulating in the world. They discussed
the resources and effort it will take to realize this vision and the
technical advances that will make it possible.
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